172
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Comparison of Photographic Screening Methods for Diabetic Retinopathy – A Meta-analysis

, ORCID Icon, , &
Pages 221-229 | Received 10 Feb 2021, Accepted 07 Apr 2022, Published online: 23 May 2022

References

  • Ehrlich R, Harris A, Ciulla T, Kheradiya N, Winston D, Wirostko B. Diabetic macular oedema: physical, physiological and molecular factors contribute to this pathological process. Acta Ophthalmol. 2010;88(3):279–291. doi:10.1111/j.1755-3768.2008.01501.x.
  • Williams R, Airey M, Baxter H, Forrester J, Kennedy-Martin T, Girach A. Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye (Lond). 2004;18(10):963–983. doi:10.1038/sj.eye.6701476.
  • Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–1053. doi:10.2337/diacare.27.5.1047.
  • Grading diabetic retinopathy from stereoscopic color fundus photographs–an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98(5 Suppl):786–806.
  • Li HK, Horton M, Bursell SE, et al. Telehealth practice recommendations for diabetic retinopathy, second edition. Telemed J E Health. 2011;17(10):814–837. doi:10.1089/tmj.2011.0075.
  • Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1. doi:10.1186/2046-4053-4-1.
  • Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98(5 Suppl):766–785.
  • Whiting PF, Rutjes AWS, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–536. doi:10.7326/0003-4819-155-8-201110180-00009.
  • Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005;58(9):882–893. doi:10.1016/j.jclinepi.2005.01.016.
  • Hedges LV, Tipton E, Johnson MC. Robust variance estimation in meta-regression with dependent effect size estimates. Res Synth Methods. 2010;1(1):39–65. doi:10.1002/jrsm.5.
  • Retinal Photographic Screening for Diabetic Eye Disease: A British Diabetic Association Report. London: British Diabetic Association; 1997.
  • Mitchell P, Foram S. Guidelines for the Management of Diabetic Retinopathy. Barton, ACT: Australian Diabetes Society; 2008.
  • Beaser RS, Turell WF, Howson A. Strategies to improve prevention and management in diabetic retinopathy: Qualitative insights from a mixed-methods study. Diabetes Spectr. 2018;31(1):65–74. doi:10.2337/ds16-0043.
  • Moss SE, Klein R, Klein BE. Factors associated with having eye examinations in persons with diabetes. Arch Fam Med. 1995;4(6):529–534. doi:10.1001/archfami.4.6.529.
  • Hartnett ME, Key IJ, Loyacano NM. Perceived barriers to diabetic eye care: qualitative study of patients and physicians. Arch Ophthalmol. 2005;123(3):387–391. doi:10.1001/archopht.123.3.387.
  • Walker EA, Basch CE, Howard CJ, Zybert PA, Kromholz WN, Shamoon H. Incentives and barriers to retinopathy screening among African-Americans with diabetes. J Diabetes Complications. 1997;11(5):298–306. doi:10.1016/S1056-8727(96)00121-3.
  • Puent BD, Nichols KK. Patients’ perspectives on noncompliance with diabetic retinopathy standard of care guidelines. Optometry. 2004;75(11):709–716. doi:10.1016/S1529-1839(04)70223-7.
  • Ellish NJ, Royak-Schaler R, Passmore SR, Higginbotham EJ. Knowledge, attitudes, and beliefs about dilated eye examinations among African-Americans. Invest Ophthalmol Vis Sci. 2007;48(5):1989–1994. doi:10.1167/iovs.06-0934.
  • Simmons D, Lillis S, Swan J, Haar J. Discordance in perceptions of barriers to diabetes care between patients and primary care and secondary care. Diabetes Care. 2007;30(3):490–495. doi:10.2337/dc06-2338.
  • Putzer GJ, Ramirez AM, Sneed K, Brownlee HJ, Roetzheim RG, Campbell RJ. Prevalence of patients with type 2 diabetes mellitus reaching the American Diabetes Association’s target guidelines in a university primary care setting. South Med J. 2004;97(2):145–148. doi:10.1097/01.SMJ.0000076385.58128.92.
  • Hazin R, Barazi MK, Summerfield M. Challenges to establishing nationwide diabetic retinopathy screening programs. Curr Opin Ophthalmol. 2011;22(3):174–179. doi:10.1097/ICU.0b013e32834595e8.
  • Abramoff MD, Niemeijer M, Russell SR. Automated detection of diabetic retinopathy: barriers to translation into clinical practice. Expert Rev Med Devices. 2010;7(2):287–296. doi:10.1586/erd.09.76.
  • Gulshan V, Peng L, Coram M, et al. Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs. JAMA. 2016;316(22):2402–2410. doi:10.1001/jama.2016.17216.
  • Silva PS, Cavallerano JD, Sun JK, Soliman AZ, Aiello LM, Aiello LP. Peripheral lesions identified by mydriatic ultrawide field imaging: distribution and potential impact on diabetic retinopathy severity. Ophthalmology. 2013;120(12):2587–2595. doi:10.1016/j.ophtha.2013.05.004.
  • Price LD, Au S, Chong NV. Optomap ultrawide field imaging identifies additional retinal abnormalities in patients with diabetic retinopathy. Clin Ophthalmol. 2015;9:527–531. doi:10.2147/OPTH.S79448.
  • Ghasemi Falavarjani K, Tsui I, Sadda SR. Ultra-wide-field imaging in diabetic retinopathy; an overview. J Curr Ophthalmol. 2016;28(2):57–60. doi:10.1016/j.joco.2016.04.001.
  • Silva PS, Cavallerano JD, Haddad NM, Kwak H, Dyer KH, Omar AF, Shikari H, Aiello LM, Sun JK, Aiello LP. Peripheral lesions identified on ultrawide field imaging predict increased risk of diabetic retinopathy progression over 4 years. Ophthalmology. 2015;122(5):949–956. doi:10.1016/j.ophtha.2015.01.008.
  • Bragge P, Gruen RL, Chau M, Forbes A, Taylor HR. Screening for presence or absence of diabetic retinopathy: a meta-analysis. Arch Ophthalmol. 2011;129(4):435–444. doi:10.1001/archophthalmol.2010.319.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.